HCPLive 5 Stories in Under 5: Week of 08/24
Welcome to HCPLive's 5 Stories in Under 5—your quick, must-know recap of the top 5 healthcare stories from the past week, all in under 5 minutes. Stay informed, stay ahead, and let’s dive into the latest updates impacting clinicians and healthcare providers like you!
Interested in a more traditional, text rundown? Check out the HCPFive!
FDA Accepts Priority Review Application of Omidubicel for Severe Aplastic Anemia
The FDA accepted a priority review application for omidubicel, a cell therapy under investigation for severe aplastic anemia.
FDA Approves REMS Label Update for Sparsentan…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.